Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis

To the Editor: Systemic mastocytosis is an uncommon and potentially misdiagnosed condition. Its hallmark is the accumulation and abnormal proliferation of mast cells in various tissues. A two-month-old boy was referred to our facility with numerous bullae on the skin and unilateral periorbital cellu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2004-02, Vol.350 (7), p.735-736
Hauptverfasser: Tolar, Jakub, Tope, Whitney D, Neglia, Joseph P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 736
container_issue 7
container_start_page 735
container_title The New England journal of medicine
container_volume 350
creator Tolar, Jakub
Tope, Whitney D
Neglia, Joseph P
description To the Editor: Systemic mastocytosis is an uncommon and potentially misdiagnosed condition. Its hallmark is the accumulation and abnormal proliferation of mast cells in various tissues. A two-month-old boy was referred to our facility with numerous bullae on the skin and unilateral periorbital cellulitis. The child was inconsolable, and his skin lesions, which had been present since birth, progressed into subcutaneous nodules, plaques, and tumors, which were excoriated. He had hepatomegaly and wheezing. Findings on examination of biopsy specimens of the skin and bone marrow were consistent with the diagnosis of systemic mastocytosis. There were no bony lesions, and there . . .
doi_str_mv 10.1056/NEJM200402123500723
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_223948633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>546116621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-aa1cf3a4dcd108054da7d53f43c14d3240a52eeb8d0967ebb1cc5a61810f94973</originalsourceid><addsrcrecordid>eNp9kM1Lw0AQxRdRbKz-BYIErxKd_crHUUrVllZB6zlsNrM01WTr7ubQ_95IC17EOcww8HvvwSPkksItBZnePU_nSwYggFHGJUDG-BGJqOQ8EQLSYxIBsDwRWcFH5Mz7DQxDRXFKRsNOIZNpROYL7D9scA12mLyixm2wLp5166ZqQmO72AxvWGO8cqhCi12IrYnfdj5g2-h4qXywehesb_w5OTHq0-PF4Y7J-8N0NXlKFi-Ps8n9ItEipyFRimrDlah1TSEHKWqV1ZIbwTUVNWcClGSIVV5DkWZYVVRrqVKaUzCFKDI-Jtd7362zXz36UG5s77ohsmSMFyJPOR8gvoe0s947NOXWNa1yu5JC-VNf-Ud9g-rqYN1XLda_mkNfA3CzB9rWlx1u2n_tvgEmyXbH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>223948633</pqid></control><display><type>article</type><title>Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Tolar, Jakub ; Tope, Whitney D ; Neglia, Joseph P</creator><creatorcontrib>Tolar, Jakub ; Tope, Whitney D ; Neglia, Joseph P</creatorcontrib><description>To the Editor: Systemic mastocytosis is an uncommon and potentially misdiagnosed condition. Its hallmark is the accumulation and abnormal proliferation of mast cells in various tissues. A two-month-old boy was referred to our facility with numerous bullae on the skin and unilateral periorbital cellulitis. The child was inconsolable, and his skin lesions, which had been present since birth, progressed into subcutaneous nodules, plaques, and tumors, which were excoriated. He had hepatomegaly and wheezing. Findings on examination of biopsy specimens of the skin and bone marrow were consistent with the diagnosis of systemic mastocytosis. There were no bony lesions, and there . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM200402123500723</identifier><identifier>PMID: 14960756</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Acetates - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Drug Therapy, Combination ; Humans ; Infant ; Leukotriene Antagonists - therapeutic use ; Male ; Mastocytosis, Systemic - drug therapy ; Prednisone - therapeutic use ; Quinolines - therapeutic use</subject><ispartof>The New England journal of medicine, 2004-02, Vol.350 (7), p.735-736</ispartof><rights>Copyright © 2004 Massachusetts Medical Society. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-aa1cf3a4dcd108054da7d53f43c14d3240a52eeb8d0967ebb1cc5a61810f94973</citedby><cites>FETCH-LOGICAL-c481t-aa1cf3a4dcd108054da7d53f43c14d3240a52eeb8d0967ebb1cc5a61810f94973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM200402123500723$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/223948633?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,2745,2746,26082,27903,27904,52361,54043,64362,64366,72216</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14960756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tolar, Jakub</creatorcontrib><creatorcontrib>Tope, Whitney D</creatorcontrib><creatorcontrib>Neglia, Joseph P</creatorcontrib><title>Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>To the Editor: Systemic mastocytosis is an uncommon and potentially misdiagnosed condition. Its hallmark is the accumulation and abnormal proliferation of mast cells in various tissues. A two-month-old boy was referred to our facility with numerous bullae on the skin and unilateral periorbital cellulitis. The child was inconsolable, and his skin lesions, which had been present since birth, progressed into subcutaneous nodules, plaques, and tumors, which were excoriated. He had hepatomegaly and wheezing. Findings on examination of biopsy specimens of the skin and bone marrow were consistent with the diagnosis of systemic mastocytosis. There were no bony lesions, and there . . .</description><subject>Acetates - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Humans</subject><subject>Infant</subject><subject>Leukotriene Antagonists - therapeutic use</subject><subject>Male</subject><subject>Mastocytosis, Systemic - drug therapy</subject><subject>Prednisone - therapeutic use</subject><subject>Quinolines - therapeutic use</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kM1Lw0AQxRdRbKz-BYIErxKd_crHUUrVllZB6zlsNrM01WTr7ubQ_95IC17EOcww8HvvwSPkksItBZnePU_nSwYggFHGJUDG-BGJqOQ8EQLSYxIBsDwRWcFH5Mz7DQxDRXFKRsNOIZNpROYL7D9scA12mLyixm2wLp5166ZqQmO72AxvWGO8cqhCi12IrYnfdj5g2-h4qXywehesb_w5OTHq0-PF4Y7J-8N0NXlKFi-Ps8n9ItEipyFRimrDlah1TSEHKWqV1ZIbwTUVNWcClGSIVV5DkWZYVVRrqVKaUzCFKDI-Jtd7362zXz36UG5s77ohsmSMFyJPOR8gvoe0s947NOXWNa1yu5JC-VNf-Ud9g-rqYN1XLda_mkNfA3CzB9rWlx1u2n_tvgEmyXbH</recordid><startdate>20040212</startdate><enddate>20040212</enddate><creator>Tolar, Jakub</creator><creator>Tope, Whitney D</creator><creator>Neglia, Joseph P</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20040212</creationdate><title>Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis</title><author>Tolar, Jakub ; Tope, Whitney D ; Neglia, Joseph P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-aa1cf3a4dcd108054da7d53f43c14d3240a52eeb8d0967ebb1cc5a61810f94973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Acetates - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Humans</topic><topic>Infant</topic><topic>Leukotriene Antagonists - therapeutic use</topic><topic>Male</topic><topic>Mastocytosis, Systemic - drug therapy</topic><topic>Prednisone - therapeutic use</topic><topic>Quinolines - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tolar, Jakub</creatorcontrib><creatorcontrib>Tope, Whitney D</creatorcontrib><creatorcontrib>Neglia, Joseph P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tolar, Jakub</au><au>Tope, Whitney D</au><au>Neglia, Joseph P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2004-02-12</date><risdate>2004</risdate><volume>350</volume><issue>7</issue><spage>735</spage><epage>736</epage><pages>735-736</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>To the Editor: Systemic mastocytosis is an uncommon and potentially misdiagnosed condition. Its hallmark is the accumulation and abnormal proliferation of mast cells in various tissues. A two-month-old boy was referred to our facility with numerous bullae on the skin and unilateral periorbital cellulitis. The child was inconsolable, and his skin lesions, which had been present since birth, progressed into subcutaneous nodules, plaques, and tumors, which were excoriated. He had hepatomegaly and wheezing. Findings on examination of biopsy specimens of the skin and bone marrow were consistent with the diagnosis of systemic mastocytosis. There were no bony lesions, and there . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>14960756</pmid><doi>10.1056/NEJM200402123500723</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 2004-02, Vol.350 (7), p.735-736
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_journals_223948633
source MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; New England Journal of Medicine
subjects Acetates - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Drug Therapy, Combination
Humans
Infant
Leukotriene Antagonists - therapeutic use
Male
Mastocytosis, Systemic - drug therapy
Prednisone - therapeutic use
Quinolines - therapeutic use
title Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T06%3A32%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leukotriene-Receptor%20Inhibition%20for%20the%20Treatment%20of%20Systemic%20Mastocytosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Tolar,%20Jakub&rft.date=2004-02-12&rft.volume=350&rft.issue=7&rft.spage=735&rft.epage=736&rft.pages=735-736&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM200402123500723&rft_dat=%3Cproquest_cross%3E546116621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=223948633&rft_id=info:pmid/14960756&rfr_iscdi=true